Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broncho-Vaxom for infection prevention and immune modulation in asthma
2016-001213-24Phase 4Active
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Apr 2016
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of OM-85 in asthma, sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Total asthma exacerbations within 18 months. Started Apr 2016; status: active.
02
Drugs
OM-85
03
Conditions
asthma
Beyond the preview
Go deeper on 2016-001213-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001213-24.